BF.11 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,918 results for “BF.11”

Trials

View all 1405 →

Evaluation of biomarkers in BF treatment (BF-LRG)

20 participants

Phase I Pharmacokinetic Study (BF-BLOCK)

20 participants · First posted Aug 25, 2011

Active, not recruiting

SSB 11-02 (SSB 11-02)

150 participants

Drugs

View all 624 →

11C-BF-227

BF-114

BF-688

Organizations

View all 345 →

KITASATO UNIVERSITY

Japan

Canbex Therapeutics Ltd.

United Kingdom

Rezolute

United States

News

View all 2544 →

FDA Restricts Emergency Use Authorization for AstraZeneca's Evusheld in the US

Mabwell's Anti-IL-11 Antibody 9MW3811 Becomes World's First IL-11 Therapeutic to Enter Phase II for Pathological Scarring

MindMed Doses First Patient in Phase 2b Trial of MM120 for Generalized Anxiety Disorder

Page 1 of 492